Alkermes

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.

About ALKS

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.

CEO

Richard F. Pops

CEORichard F. Pops

Employees

1,800

Employees1,800

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2011

Founded2011

Employees

1,800

Employees1,800

ALKS Key Statistics

Market cap

4.94B

Market cap4.94B

Price-Earnings ratio

13.88

Price-Earnings ratio13.88

Dividend yield

—

Dividend yield—

Average volume

1.64M

Average volume1.64M

High today

$30.24

High today$30.24

Low today

$28.70

Low today$28.70

Open price

$28.89

Open price$28.89

Volume

2.35M

Volume2.35M

52 Week high

$36.45

52 Week high$36.45

52 Week low

$25.56

52 Week low$25.56

ALKS News

TipRanks 3d

Alkermes initiated with an Overweight at Wells Fargo

Wells Fargo initiated coverage of Alkermes (ALKS) with an Overweight rating and $44 price target. The firm contends that alixorexton will work in narcolepsy and...

Analyst ratings

71%

of 17 ratings

Buy

70.6%

Hold

29.4%

Sell

People also own

Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.